Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA‐A receptor potentiation
- 31 October 2007
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 584 (3), 789-800
- https://doi.org/10.1113/jphysiol.2007.142794
Abstract
Neurosteroids are potent modulators of GABA-A receptors. We have examined the time course of development of potentiation of alpha1beta2gamma2L GABA-A receptors during coapplication of GABA and an endogenous neurosteroid (3alpha,5alpha)-3-hydroxypregnan-20-one (3alpha5alphaP). The simultaneous application of 3alpha5alphaP with 5 microm GABA resulted in a biphasic rising phase of current with time constants of 50-60 ms for the rapid phase and 0.3-3 s for the slow phase. The properties of the rapid phase were similar at all steroid concentrations but the time constant of the slower phase became successively shorter as the steroid concentration was increased. Potentiation developed very rapidly (tau = 130 ms) when cells were preincubated with 300 nm 3alpha5alphaP before application of GABA + 3alpha5alphaP, and in outside-out patch recordings, suggesting that steroid diffusion to intracellular compartments competes with receptor potentiation by depleting the cell membrane of steroid. Very low steroid concentrations (3-5 nm) potentiated GABA responses but the effects took minutes to develop. Intracellular accumulation of a fluorescent steroid analogue followed a similar time course, suggesting that slow potentiation results from slow accumulation within plasma membrane rather than indirect effects, such as activation of second messenger systems. In cell-attached single-channel recordings, where 3alpha5alphaP is normally applied through the pipette solution, addition of steroid to the bath solution dramatically shifted the steroid potentiation concentration-effect curve to lower steroid concentrations. We propose that bath-supplied steroid compensates for the diffusion of pipette-supplied steroid out of the patch to the rest of the cell membrane and/or intracellular compartments. The findings suggest that previous studies overestimate the minimum concentration of steroid capable of potentiating GABA actions at GABA-A receptors. The results have implications for the physiological role of endogenous neurosteroids.Keywords
This publication has 33 references indexed in Scilit:
- Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat α1β2γ2L GABAA ReceptorPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- Auto-modulation of neuroactive steroids on GABAA receptors: A novel pharmacological effectNeuropharmacology, 2007
- Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesisProceedings of the National Academy of Sciences, 2006
- Intracellular sterol transport and distributionCurrent Opinion in Cell Biology, 2006
- Dual Potentiating and Inhibitory Actions of a Benz[e]indene Neurosteroid Analog on Recombinant α1β2γ2 GABAA ReceptorsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Structure of caveolaeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Slow Actions of Neuroactive Steroids at GABAAReceptorsJournal of Neuroscience, 2004
- Production of 5α-Reduced Neurosteroids Is Developmentally Regulated and Shapes GABAAMiniature IPSCs in Lamina II of the Spinal CordJournal of Neuroscience, 2004
- Modulation of GABAA receptor channel gating by pentobarbitalThe Journal of Physiology, 2001
- Modulation of GABAA receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABAA receptor isoformsCanadian Journal of Physiology and Pharmacology, 1998